US 7,531,570 B2
Treatment of diseases using ICE inhibitors
John C R Randle, Brookline, Mass. (US)
Assigned to Vertex Pharmaceuticals Incorporated, Cambridge, Mass. (US)
Filed on May 27, 2005, as Appl. No. 11/140,649.
Claims priority of provisional application 60/574993, filed on May 27, 2004.
Prior Publication US 2005/0267101 A1, Dec. 01, 2005
Int. Cl. A61K 31/40 (2006.01)
U.S. Cl. 514—422 7 Claims
 
1. A method for ameliorating or treating Cryopyrin-associated Periodic Syndromes, Muckle-Wells Syndrome, Familial Cold Autoinflammatory Syndrome, Familial Mediterranean Fever, Chronic Infantile Neurological Cutaneous and Articular Syndrome, Neonatal Onset Multisystem Inflammatory Disease, TNFR1-Associated Periodic Syndrome, Hyper-IgD periodic fever Syndrome, Blau's syndrome, systemic onset juvenile idiopathic arthritis, or macrophage activation syndrome in a subject, comprising administering a compound or a pharmaceutical composition comprising said compound to said subject, wherein said compound is

OG Complex Work Unit Drawing
and each stereoisomerthereof, including:

OG Complex Work Unit Drawing